NewLimit
Developing epigenetic reprogramming medicines to extend human healthspan.
Company facts
- Founded
- 2021
- Employees
- 50
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $45M · 2025
Open positions
Group Lead, Immunology
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist, Metabolism
Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Senior Scientist / Scientist, In Vivo Pharmacology
Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist/Senior Scientist, Immunology
Design and run immunology experiments to identify epigenetic therapies for inflammatory and autoimmune diseases, focusing on T cell and regulatory T cell biology.
Scientist/Senior Scientist
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…